Ibex LTD Form 4 insider transactions

Director Patrick McGinnis acquired 5,000 common shares of IBEX Ltd on February 14, 2025, through the grant of Restricted Stock Units (RSUs).

Director Mohammedulla Khaishgi of Ibex Ltd. reports selling common shares in multiple transactions on February 13 and 14, 2025.

IBEX Ltd.'s CEO, Robert Thomas Dechant, sold 5,000 common shares at an average price of $27.5552 on February 14, 2025.

Paul Joseph Inson, Chief People Officer of IBEX Ltd, sold 8,954 common shares on February 14, 2025, at a weighted average price of $27.5318.

Chief People Officer Paul Joseph Inson of Ibex Ltd. reports exercising stock options and selling shares on February 11, 2025.

Chief People Officer of IBEX Ltd., Paul Joseph Inson, sold 8,044 common shares at an average price of $25.0028 on February 11, 2025.

Christina Alice Trofimuk-O'Connor, Chief Legal Officer of IBEX Ltd, reports the acquisition and disposal of common shares and stock options on February 12, 2025.

Christina Alice Trofimuk-O'Connor, Chief Legal Officer of IBEX Ltd., reports exercising stock options and selling shares on February 11, 2025.

IBEX Ltd CEO Robert Thomas Dechant sold a portion of his IBEX shares in transactions on February 10th and 11th, 2025.

Director Mohammedulla Khaishgi of Ibex Ltd reports selling common shares in a series of transactions between February 10 and February 12, 2025.

Chief People Officer of IBEX Ltd., Paul Joseph Inson, sold 1,956 common shares of the company on February 7, 2025, at a weighted average price of $25.0019.

Bruce Neil Dawson, Chief Sales and CS Officer of IBEX Ltd, sold 13,500 common shares of the company on February 7, 2025, at a price of $24 per share.

Director Mohammedulla Khaishgi sold shares of Ibex Ltd. on February 7, 2025.

IBEX Ltd's CEO, Robert Thomas Dechant, sold 2,621 common shares of the company at an average price of $25.0015 on February 7, 2025.

A director of Ibex Ltd, Mohammedulla Khaishgi, sold a significant number of common shares in multiple transactions over two days.

CEO Robert Dechant of IBEX Ltd. reports selling a portion of his holdings in company stock.

A director of Ibex Ltd, Mohammedulla Khaishgi, sold a total of 10,842 common shares in multiple transactions on January 24th and 27th, 2025.

Director Mohammedulla Khaishgi reported the sale of Ibex Ltd common shares on January 21, 2025, according to a Form 4 filing.

IBEX Ltd's CEO, Robert Thomas Dechant, sold 1,792 common shares at an average price of $22.5019 per share on January 21, 2025, under a pre-arranged 10b5-1 trading plan.

A director of IBEX Ltd, Shuja Keen, sold 11,199 common shares at a weighted average price of $21.9522 per share on December 30, 2024.

PineBridge GEM II, along with related parties, sold 20,000 IBEX shares at a weighted average price of $19.9989, reducing their holdings to 1,309,781 shares.

Director Shuja Keen of IBEX Ltd sold a total of 12,184 common shares in two separate transactions on December 13th and 16th, 2024.

A director of Ibex Ltd, Shuja Keen, sold a total of 17,000 common shares in two separate transactions on December 12, 2024.

PineBridge GEM II sold 60,958 shares of IBEX Ltd at a weighted average price of $20.12, with individual transactions ranging from $20.00 to $20.258.

PineBridge GEM II G.P., L.P., along with related parties, sold a total of 30,808 IBEX Ltd shares in multiple transactions on December 5th and 9th, 2024.

PineBridge GEM II G.P., L.P., along with related entities and individuals, sold a total of 149,192 common shares of IBEX Ltd across three days, reducing their holdings.

Gerard J Kleisterlee, a director at IBEX Ltd, sold 5,000 common shares at a price of $20.55 per share on November 26, 2024.

A director of Ibex Ltd, Shuja Keen, sold a total of 37,569 common shares in two separate transactions on November 20 and 21, 2024.

PineBridge GEM II, along with related parties, sold a total of 148,000 IBEX shares in multiple transactions over two days, reducing their holdings.

Resource Group International Ltd sold 3,562,341 common shares of IBEX Ltd back to the company for $19.65 per share and received a convertible promissory note as part of the consideration.